Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised.

Wendering DJ, Amini L, Schlickeiser S, Reinke P, Volk HD, Schmueck-Henneresse M.

Front Immunol. 2019 Feb 5;10:150. doi: 10.3389/fimmu.2019.00150. eCollection 2019.

2.

Generating Multiple Kidney Progenitors and Cell Types from Human Pluripotent Stem Cells.

Hariharan K, Reinke P, Kurtz A.

Methods Mol Biol. 2019;1926:103-115. doi: 10.1007/978-1-4939-9021-4_9.

PMID:
30742266
3.

Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.

Moll G, Ankrum JA, Kamhieh-Milz J, Bieback K, Ringdén O, Volk HD, Geissler S, Reinke P.

Trends Mol Med. 2019 Feb;25(2):149-163. doi: 10.1016/j.molmed.2018.12.006. Epub 2019 Jan 30. Review.

4.

From Alloy to Oxide: Capturing the Early Stages of Oxidation on Ni-Cr(100) Alloys.

Blades WH, Reinke P.

ACS Appl Mater Interfaces. 2018 Nov 19. doi: 10.1021/acsami.8b15210. [Epub ahead of print]

PMID:
30452217
5.

Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Latham SL, Ehmke N, Reinke PYA, Taft MH, Eicke D, Reindl T, Stenzel W, Lyons MJ, Friez MJ, Lee JA, Hecker R, Frühwald MC, Becker K, Neuhann TM, Horn D, Schrock E, Niehaus I, Sarnow K, Grützmann K, Gawehn L, Klink B, Rump A, Chaponnier C, Figueiredo C, Knöfler R, Manstein DJ, Di Donato N.

Nat Commun. 2018 Nov 19;9(1):4930. doi: 10.1038/s41467-018-07404-6.

6.

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population.

Wagner DL, Amini L, Wendering DJ, Burkhardt LM, Akyüz L, Reinke P, Volk HD, Schmueck-Henneresse M.

Nat Med. 2019 Feb;25(2):242-248. doi: 10.1038/s41591-018-0204-6. Epub 2018 Oct 29.

PMID:
30374197
7.

Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells.

Pinzur L, Akyuez L, Levdansky L, Blumenfeld M, Volinsky E, Aberman Z, Reinke P, Ofir R, Volk HD, Gorodetsky R.

J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1079-1092. doi: 10.1002/jcsm.12342. Epub 2018 Oct 18.

8.

Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Latham SL, Ehmke N, Reinke PYA, Taft MH, Eicke D, Reindl T, Stenzel W, Lyons MJ, Friez MJ, Lee JA, Hecker R, Frühwald MC, Becker K, Neuhann TM, Horn D, Schrock E, Niehaus I, Sarnow K, Grützmann K, Gawehn L, Klink B, Rump A, Chaponnier C, Figueiredo C, Knöfler R, Manstein DJ, Di Donato N.

Nat Commun. 2018 Oct 12;9(1):4250. doi: 10.1038/s41467-018-06713-0. Erratum in: Nat Commun. 2018 Nov 19;9(1):4930.

9.

Parallel generation of easily selectable multiple nephronal cell types from human pluripotent stem cells.

Hariharan K, Stachelscheid H, Rossbach B, Oh SJ, Mah N, Schmidt-Ott K, Kurtz A, Reinke P.

Cell Mol Life Sci. 2019 Jan;76(1):179-192. doi: 10.1007/s00018-018-2929-2. Epub 2018 Oct 11.

PMID:
30310934
10.

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.

Sommerer C, Witzke O, Lehner F, Arns W, Reinke P, Eisenberger U, Vogt B, Heller K, Jacobi J, Guba M, Stahl R, Hauser IA, Kliem V, Wüthrich RP, Mühlfeld A, Suwelack B, Duerr M, Paulus EM, Zeier M, Porstner M, Budde K; ZEUS and HERAKLES study investigators.

BMC Nephrol. 2018 Sep 19;19(1):237. doi: 10.1186/s12882-018-1031-1.

11.

Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty.

Winkler T, Perka C, von Roth P, Agres AN, Plage H, Preininger B, Pumberger M, Geissler S, Hagai EL, Ofir R, Pinzur L, Eyal E, Stoltenburg-Didinger G, Meisel C, Consentius C, Streitz M, Reinke P, Duda GN, Volk HD.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):880-897. doi: 10.1002/jcsm.12316. Epub 2018 Sep 19.

12.

BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study.

Blazquez-Navarro A, Dang-Heine C, Wittenbrink N, Bauer C, Wolk K, Sabat R, Westhoff TH, Sawitzki B, Reinke P, Thomusch O, Hugo C, Or-Guil M, Babel N.

EBioMedicine. 2018 Aug;34:113-121. doi: 10.1016/j.ebiom.2018.07.017. Epub 2018 Jul 30.

13.

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.

Eisenberger U, Budde K, Lehner F, Sommerer C, Reinke P, Witzke O, Wüthrich RP, Stahl R, Heller K, Suwelack B, Mühlfeld A, Hauser IA, Nadalin S, Porstner M, Arns W; ZEUS Study Investigators.

BMC Nephrol. 2018 Jun 28;19(1):154. doi: 10.1186/s12882-018-0950-1.

14.

Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study.

Schachtner T, Otto NM, Reinke P.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2060-2066. doi: 10.1093/ndt/gfy148.

PMID:
29868874
15.

Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis.

Pappritz K, Savvatis K, Miteva K, Kerim B, Dong F, Fechner H, Müller I, Brandt C, Lopez B, González A, Ravassa S, Klingel K, Diez J, Reinke P, Volk HD, Van Linthout S, Tschöpe C.

FASEB J. 2018 Jun 4:fj201701408R. doi: 10.1096/fj.201701408R. [Epub ahead of print]

PMID:
29863913
16.

Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.

Landwehr-Kenzel S, Zobel A, Hoffmann H, Landwehr N, Schmueck-Henneresse M, Schachtner T, Roemhild A, Reinke P.

Kidney Int. 2018 Jun;93(6):1452-1464. doi: 10.1016/j.kint.2018.01.021.

PMID:
29792274
17.

Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.

Zimmermann H, Babel N, Dierickx D, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Bachy E, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S, Trappe RU.

Transplantation. 2018 Nov;102(11):1914-1923. doi: 10.1097/TP.0000000000002269.

PMID:
29757894
18.

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach.

Blazquez-Navarro A, Schachtner T, Stervbo U, Sefrin A, Stein M, Westhoff TH, Reinke P, Klipp E, Babel N, Neumann AU, Or-Guil M.

PLoS Comput Biol. 2018 May 10;14(5):e1005998. doi: 10.1371/journal.pcbi.1005998. eCollection 2018 May.

19.

Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.

Sommerer C, Duerr M, Witzke O, Lehner F, Arns W, Kliem V, Ackermann D, Guba M, Jacobi J, Hauser IA, Stahl R, Reinke P, Rath T, Veit J, Mehrabi A, Porstner M, Budde K; HERAKLES Study Group.

Am J Transplant. 2018 Dec;18(12):2965-2976. doi: 10.1111/ajt.14897. Epub 2018 Jun 3.

PMID:
29722128
20.

Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.

Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M, Doehner W, Scherbakov N, Heidecke H, Reinke P, Volk HD, Grabowski P.

PLoS One. 2018 Mar 15;13(3):e0193672. doi: 10.1371/journal.pone.0193672. eCollection 2018.

21.

Prevalence and Clinical Correlates of Chronic Hepatitis E Infection in German Renal Transplant Recipients With Elevated Liver Enzymes.

Choi M, Hofmann J, Köhler A, Wang B, Bock CT, Schott E, Reinke P, Nickel P.

Transplant Direct. 2018 Feb 2;4(2):e341. doi: 10.1097/TXD.0000000000000758. eCollection 2018 Feb.

22.

Evolution of NiO Island Size Distributions during the Oxidation of a Ni-5Cr Alloy: Experiment and Modeling.

Ramanathan R, Ramalingam G, Perepezko JH, Reinke P, Voorhees PW.

ACS Appl Mater Interfaces. 2018 Mar 14;10(10):9136-9146. doi: 10.1021/acsami.7b18539. Epub 2018 Mar 5.

PMID:
29446919
23.

Transplantectomy is associated with presensitization with donor-reactive T cells and graft failure after kidney retransplantation: a cohort study.

Schachtner T, Otto NM, Stein M, Reinke P.

Nephrol Dial Transplant. 2018 May 1;33(5):889-896. doi: 10.1093/ndt/gfy002.

PMID:
29401311
24.

Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients.

Schachtner T, Zaks M, Otto NM, Kahl A, Reinke P.

Transpl Infect Dis. 2018 Apr;20(2):e12848. doi: 10.1111/tid.12848. Epub 2018 Mar 1.

PMID:
29359836
25.

The effect of induction therapy on established CMV specific T cell immunity in living donor kidney transplantation.

Stranavova L, Hruba P, Girmanova E, Tycova I, Slavcev A, Fronek J, Slatinska J, Reinke P, Volk HD, Viklicky O.

Physiol Res. 2018 May 4;67(2):251-260. Epub 2018 Jan 5.

26.

End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.

Zimmermann H, Denecke T, Dreyling MH, Franzius C, Reinke P, Subklewe M, Amthauer H, Kneba M, Riess H, Trappe RU.

Transplantation. 2018 May;102(5):868-875. doi: 10.1097/TP.0000000000002006.

PMID:
29189632
27.

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial.

Witzke O, Nitschke M, Bartels M, Wolters H, Wolf G, Reinke P, Hauser IA, Alshuth U, Kliem V.

Transplantation. 2018 May;102(5):876-882. doi: 10.1097/TP.0000000000002024.

PMID:
29166336
28.

Pink-beam serial crystallography.

Meents A, Wiedorn MO, Srajer V, Henning R, Sarrou I, Bergtholdt J, Barthelmess M, Reinke PYA, Dierksmeyer D, Tolstikova A, Schaible S, Messerschmidt M, Ogata CM, Kissick DJ, Taft MH, Manstein DJ, Lieske J, Oberthuer D, Fischetti RF, Chapman HN.

Nat Commun. 2017 Nov 3;8(1):1281. doi: 10.1038/s41467-017-01417-3.

29.

Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.

Lehner LJ, Reinke P, Hörstrup JH, Rath T, Suwelack B, Krämer BK, Budde K, Banas B.

Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13142. Epub 2018 Jan 5.

PMID:
29052906
30.

Invited letter in response to "Predicted indirectly recognizable HLA epitopes (PIRCHE): Only the tip of the iceberg?"

Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pruß A, Schönemann C, Spierings E, Staeck O.

Am J Transplant. 2018 Feb;18(2):523-524. doi: 10.1111/ajt.14535. Epub 2017 Nov 4. No abstract available.

31.

Accelerating Patients' Access to Advanced Therapies in the EU.

Elsanhoury A, Sanzenbacher R, Reinke P, Abou-El-Enein M.

Mol Ther Methods Clin Dev. 2017 Sep 22;7:15-19. doi: 10.1016/j.omtm.2017.08.005. eCollection 2017 Dec 15. Review. No abstract available.

32.

N-terminal splicing extensions of the human MYO1C gene fine-tune the kinetics of the three full-length myosin IC isoforms.

Zattelman L, Regev R, Ušaj M, Reinke PYA, Giese S, Samson AO, Taft MH, Manstein DJ, Henn A.

J Biol Chem. 2017 Oct 27;292(43):17804-17818. doi: 10.1074/jbc.M117.794008. Epub 2017 Sep 11.

33.

Estimated Nephron Number of the Donor Kidney: Impact on Allograft Kidney Outcomes.

Schachtner T, Reinke P.

Transplant Proc. 2017 Jul - Aug;49(6):1237-1243. doi: 10.1016/j.transproceed.2017.01.086.

PMID:
28735987
34.

Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using integration free Sendai virus technology.

Rossbach B, Hildebrand L, El-Ahmad L, Stachelscheid H, Reinke P, Kurtz A.

Stem Cell Res. 2017 May;21:167-170. doi: 10.1016/j.scr.2016.09.002. Epub 2016 Sep 13.

35.

Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.

Schachtner T, Zaks M, Otto NM, Kahl A, Reinke P.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12742. Epub 2017 Jul 31.

PMID:
28665480
36.

Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.

Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pruß A, Schönemann C, Spierings E, Staeck O.

Am J Transplant. 2017 Dec;17(12):3076-3086. doi: 10.1111/ajt.14393. Epub 2017 Jul 28.

37.

Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.

Budde K, Zeier M, Witzke O, Arns W, Lehner F, Guba M, Jacobi J, Kliem V, Reinke P, Hauser IA, Vogt B, Stahl R, Rath T, Duerr M, Paulus EM, May C, Porstner M, Sommerer C; HERAKLES Study Group.

Nephrol Dial Transplant. 2017 Jun 1;32(6):1060-1070. doi: 10.1093/ndt/gfx075.

PMID:
28605781
38.

CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor.

Schachtner T, Stein M, Reinke P.

Transplantation. 2017 Oct;101(10):e315-e325. doi: 10.1097/TP.0000000000001825.

PMID:
28594749
39.

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.

Schmueck-Henneresse M, Omer B, Shum T, Tashiro H, Mamonkin M, Lapteva N, Sharma S, Rollins L, Dotti G, Reinke P, Volk HD, Rooney CM.

J Immunol. 2017 Jul 1;199(1):348-362. doi: 10.4049/jimmunol.1601494. Epub 2017 May 26.

40.

Diabetic kidney transplant recipients: Impaired infection control and increased alloreactivity.

Schachtner T, Stein M, Reinke P.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12986. Epub 2017 May 14.

PMID:
28423197
41.

Comparative characterization of decellularized renal scaffolds for tissue engineering.

Fischer I, Westphal M, Rossbach B, Bethke N, Hariharan K, Ullah I, Reinke P, Kurtz A, Stachelscheid H.

Biomed Mater. 2017 Jul 4;12(4):045005. doi: 10.1088/1748-605X/aa6c6d.

PMID:
28396578
42.

Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation.

Ziemann M, Heßler N, König IR, Lachmann N, Dick A, Ditt V, Budde K, Reinke P, Eisenberger U, Suwelack B, Klein T, Westhoff TH, Arns W, Ivens K, Habicht A, Renders L, Stippel D, Bös D, Sommer F, Görg S, Nitschke M, Feldkamp T, Heinemann FM, Kelsch R.

Nephrol Dial Transplant. 2017 May 1;32(5):880-889. doi: 10.1093/ndt/gfw462.

PMID:
28340245
43.

Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.

Schachtner T, Stein M, Reinke P.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12695. Epub 2017 May 9.

PMID:
28296035
44.

Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.

Viklicky O, Hruba P, Tomiuk S, Schmitz S, Gerstmayer B, Sawitzki B, Miqueu P, Mrazova P, Tycova I, Svobodova E, Honsova E, Janssen U, Volk HD, Reinke P.

PLoS One. 2017 Jan 13;12(1):e0169624. doi: 10.1371/journal.pone.0169624. eCollection 2017.

45.

Electronic Structure and Band Gap of Fullerenes on Tungsten Surfaces: Transition from a Semiconductor to a Metal Triggered by Annealing.

Monazami E, McClimon JB, Rondinelli J, Reinke P.

ACS Appl Mater Interfaces. 2016 Dec 21;8(50):34854-34862. Epub 2016 Dec 6.

PMID:
27998144
46.

Alternative Route to Silicene Synthesis via Surface Reconstruction on h-MoSi2 Crystallites.

Volders C, Monazami E, Ramalingam G, Reinke P.

Nano Lett. 2017 Jan 11;17(1):299-307. doi: 10.1021/acs.nanolett.6b04065. Epub 2016 Dec 27.

PMID:
27997208
47.

Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study.

Habedank D, Schefold JC, Bernhardt C, Karhausen T, Doehner W, Anker SD, Reinke P.

Cardiorenal Med. 2016 Nov;7(1):50-59. Epub 2016 Sep 21.

48.

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S.

J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19.

PMID:
27992268
49.

Increased alloreactivity and adverse outcomes in obese kidney transplant recipients are limited to those with diabetes mellitus.

Schachtner T, Stein M, Reinke P.

Transpl Immunol. 2017 Feb;40:8-16. doi: 10.1016/j.trim.2016.11.005. Epub 2016 Nov 27.

PMID:
27903445
50.

Corrigendum to "Generation of a human induced pluripotent stem cell line from urinary cells of a healthy donor using an integration free vector" [Stem Cell Res. 16/2 (2016) 314-317].

Rossbach B, Hildebrand L, El-Ahmad L, Stachelscheid H, Reinke P, Kurtz A.

Stem Cell Res. 2016 Sep;17(2):461. doi: 10.1016/j.scr.2016.09.003. No abstract available.

Supplemental Content

Loading ...
Support Center